Acorah Software Products - Accounts Production 16.6.950 false true 30 September 2024 1 October 2023 false 1 October 2024 30 September 2025 30 September 2025 14331207 D Hardy K E Hardy iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 14331207 2024-09-30 14331207 2025-09-30 14331207 2024-10-01 2025-09-30 14331207 frs-core:CurrentFinancialInstruments 2025-09-30 14331207 frs-core:ComputerEquipment 2025-09-30 14331207 frs-core:ComputerEquipment 2024-10-01 2025-09-30 14331207 frs-core:ComputerEquipment 2024-09-30 14331207 frs-core:ShareCapital 2025-09-30 14331207 frs-core:RetainedEarningsAccumulatedLosses 2025-09-30 14331207 frs-bus:PrivateLimitedCompanyLtd 2024-10-01 2025-09-30 14331207 frs-bus:FilletedAccounts 2024-10-01 2025-09-30 14331207 frs-bus:SmallEntities 2024-10-01 2025-09-30 14331207 frs-bus:AuditExempt-NoAccountantsReport 2024-10-01 2025-09-30 14331207 frs-bus:SmallCompaniesRegimeForAccounts 2024-10-01 2025-09-30 14331207 frs-core:ListedExchangeTraded 2025-09-30 14331207 frs-core:ListedExchangeTraded 2024-09-30 14331207 frs-core:CostValuation frs-core:ListedExchangeTraded 2024-09-30 14331207 frs-core:AdditionsToInvestments frs-core:ListedExchangeTraded 2025-09-30 14331207 frs-core:RevaluationsIncreaseDecreaseInInvestments frs-core:ListedExchangeTraded 2025-09-30 14331207 frs-core:CostValuation frs-core:ListedExchangeTraded 2025-09-30 14331207 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2024-09-30 14331207 frs-core:ProvisionsForImpairmentInvestments frs-core:ListedExchangeTraded 2025-09-30 14331207 frs-bus:Director1 2024-10-01 2025-09-30 14331207 frs-bus:Director1 2024-09-30 14331207 frs-bus:Director1 2025-09-30 14331207 frs-bus:CompanySecretary1 2024-10-01 2025-09-30 14331207 frs-countries:EnglandWales 2024-10-01 2025-09-30 14331207 2023-09-30 14331207 2024-09-30 14331207 2023-10-01 2024-09-30 14331207 frs-core:CurrentFinancialInstruments 2024-09-30 14331207 frs-core:ShareCapital 2024-09-30 14331207 frs-core:RetainedEarningsAccumulatedLosses 2024-09-30
Registered number: 14331207
DMHC Associates Limited
Unaudited Financial Statements
For The Year Ended 30 September 2025
DMHC Associates Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—6

Page 1
DMHC Associates Limited
Balance Sheet
As At 30 September 2025
Balance Sheet
Registered number: 14331207

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
FIXED ASSETS
Tangible Assets | 4 |  | 1,831 |  | 2,233
Investments | 5 |  | 73,547 |  | -
|  |  | 75,378 |  | 2,233
CURRENT ASSETS
Debtors | 6 | 12,890 |  | 16,122 |
Cash at bank and in hand |  | 33,581 |  | 2,391 |
|  | 46,471 |  | 18,513 |
Creditors: Amounts Falling Due Within One Year | 7 | (31,184 ) |  | (7,967 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 15,287 |  | 10,546
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 90,665 |  | 12,779
PROVISIONS FOR LIABILITIES
Deferred Taxation |  |  | (457 ) |  | (424 )
NET ASSETS |  |  | 90,208 |  | 12,355
CAPITAL AND RESERVES
Called up share capital | 8 |  | 10 |  | 10
Profit and Loss Account |  |  | 90,198 |  | 12,345
SHAREHOLDERS' FUNDS |  |  | 90,208 |  | 12,355

Page 1
Page 2
DMHC Associates Limited
Balance Sheet (continued)
As At 30 September 2025
For the year ending 30 September 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

D Hardy Director
5 January 2026

The notes on pages 3 to 6 form part of these financial statements.
Page 2
Page 3
DMHC Associates Limited
Notes to the Financial Statements
For The Year Ended 30 September 2025
Notes to the Financial Statements
1. General Information
DMHC Associates Limited is a private company, limited by shares, incorporated in England & Wales, registered number 14331207 . The registered office is Avaland House, 110 London Road, Apsley, Hemel Hempstead, Hertfordshire, HP3 9SD.
The presentation currency of the financial statements is the Pound Sterling (£).
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.
2.3. Tangible Fixed Assets and Depreciation
Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses. Depreciation is provided at rates calculated to write off the cost of the fixed assets, less their estimated residual value, over their expected useful lives on the following bases:

Computer Equipment | 25% Straightline basis

2.4. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax is recognised on timing differences between the carrying amounts of assets and liabilities in the financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable timing differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible timing differences can be utilised. The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered.
Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. Deferred tax liabilities are presented within provisions for liabilities and deferred tax assets within debtors. The measurement of deferred tax liabilities and assets reflect the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax are recognised in profit or loss for the year, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case current and deferred tax are recognised in other comprehensive income or directly in equity respectively.
Page 3
Page 4
DMHC Associates Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 September 2025
2.5. Investments
All investments in listed shares are carried at fair value determined annually and derived from the current market value. Changes in fair value are recognised in the profit and loss account.
3. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2024: NIL)
- -
4. Tangible Assets

| Computer Equipment
--- | ---
| £
Cost
As at 1 October 2024 | 2,857
Additions | 666
Disposals | (323 )
As at 30 September 2025 | 3,200
Depreciation
As at 1 October 2024 | 624
Provided during the period | 826
Disposals | (81 )
As at 30 September 2025 | 1,369
Net Book Value
As at 30 September 2025 | 1,831
As at 1 October 2024 | 2,233

5. Investments

| Listed
--- | ---
| £
Cost or Valuation
As at 1 October 2024 | -
Additions | 71,188
Revaluations | 2,359
As at 30 September 2025 | 73,547
Provision
As at 1 October 2024 | -
As at 30 September 2025 | -
Net Book Value
As at 30 September 2025 | 73,547
As at 1 October 2024 | -

Page 4
Page 5
DMHC Associates Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 September 2025
Fair value at 30 September 2025 is represented by:

| 2025 |
| £ |
Cost | 71,188 |
Revaluation | 2,539 |
| 73,547 |

6. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Trade debtors | 9,073 |  | 5,768
Prepayments and accrued income | 159 |  | 8,292
Director's loan account | 3,658 |  | 2,062
| 12,890 |  | 16,122

7. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Corporation tax | 22,407 |  | 6,377
VAT | 7,302 |  | -
Accruals and deferred income | 1,475 |  | 1,590
| 31,184 |  | 7,967

8. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 10 |  | 10

Page 5
Page 6
DMHC Associates Limited
Notes to the Financial Statements (continued)
For The Year Ended 30 September 2025
9. Directors Advances, Credits and Guarantees
Included within Debtors are the following loans to directors:

| As at 1 October 2024 | Amounts advanced | Amounts repaid | Amounts written off | As at 30 September 2025
--- | --- | --- | --- | --- | ---
| £ | £ | £ | £ | £
Mr Duncan Hardy | 2,062 | 6,554 | 4,958 | - | 3,658

The above loan is unsecured, interest free and repayable on demand.
10. Reserves

| 2025 |
| £ |
At 1 October 2024 | 12,345 |
Profit for the year | 77,853 |
Dividends | - |
At 30 September 2025 | 90,198 |

The company's investment in listed shares have been revalued. Revaluation gains have been credited to the profit and loss account in line with the reporting requirements under FRS102 1A. On 30 September 2025 the company's retained earnings included non-distributable reserves of £1,971 (2024: £Nil) resulting from the revaluation.
Page 6